Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia

References

• Bashir Z I, Bortolotto Z A, Davies C H, Berretta N, Irving A J, Seal A J, Henley J M, Jane D E, Watkins J C, Collingridge G L. Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature 1993; 363: 347–350
   PubMed Web of Science ®Google Scholar
• Bellinger F P, Madamba S, Siggins G R. Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CAl hippocampus. Brain Res 1993; 628: 227–234
   Web of Science ®Google Scholar
• Bliss T VP, Lømo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973; 232: 331–356
   PubMed Web of Science ®Google Scholar
• Bliss T VP, Collingridge G L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31–39
   PubMed Web of Science ®Google Scholar
• Bukrinsky M I, Nottet H SLM, Schmidtmayerova H, Dubrovsky L, Mullins M E, Lipton S A, Gendelman H E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type-1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181: 735–745
   PubMed Web of Science ®Google Scholar
• Coan E J, Saywood W, Collingridge G L. MK-801 blocks NMDA receptor-mediated synaptic transmission and long-term potentiation in rat hippocampal slices. Neurosci Lett 1987; 80: 111–114
   Google Scholar
• Cunningham A J, Murray C A, O'Neill L AJ, Lynch M A, O'Connor J J. Interleukin-1β (IL-1β) and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 1996; 203: 17–20
   PubMed Web of Science ®Google Scholar
• Dawson V L, Dawson T M, Uhl G R, Snyder S H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993; 90: 3256–3259
   PubMed Web of Science ®Google Scholar
• Epstein L G, Gendelman H E. Human immunodeficiency virus type 1 infection of the nervous system: pathogeneic mechanisms. Ann Neurol 1993; 33: 277–287
   Google Scholar
• Everall I P, Luthbert P J, Lantos P L. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991; 337: 1119–1121
   PubMed Web of Science ®Google Scholar
• Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A. Human immunodeficiency type 1 (HIV-1) infection of central nervous system: an evaluation of cytokines in cerebrospinal fluids. J Neuroimmunol 1989; 23: 109–116
   PubMed Web of Science ®Google Scholar
• Gelbard H A, Nottet H SLM, Dzenko K A, Jett M, Genis P, White R, Wang L, Choi Y B, Zhang D, Lipton S A, Swindells S, Epstein L G, Gendelman H E. Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1994; 68: 4628–4635
   PubMed Web of Science ®Google Scholar
• Gendelman H E, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R. The neuropathogenesis of HIV-1 dementia. AIDS 1997; 97(11)S35–S45
   Google Scholar
• Gendelman H E, Orenstein J, Martin M A, Ferrua C, Mitra R, Phipps T, Wahl L A, Lane H C, Fauci A S, Burke D, Skillman D, Meltzer M S. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony stimulating factor 1-treated monocytes. J Exp Med 1988; 167: 1428–1441
   PubMed Web of Science ®Google Scholar
• Genis P, Jett M, Bernton E W, Boyle T, Gelbard H A, Dzenko K, Keane R W, Resnick L, Volsky D J, Epstein L G, Gendelman H E. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HFV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176: 1703–1718
   Google Scholar
• Glass J D, Johnson R T. Human immunodeficiency virus and the brain. Ann Rev Neurosci 1996; 19: 1–26
   PubMed Web of Science ®Google Scholar
• Glass J D, Fedor H, Wesselingh S L, McArthur J C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlation with dementia. Ann Neurol 1995; 38: 755–762
   PubMed Web of Science ®Google Scholar
• Haas H S, Schauenstein K. Neuroimmunomodulation via limbic structure—the neuroanatomy of psychoimmunology. Prog Neurobiol 1997; 51: 195–222
   PubMed Web of Science ®Google Scholar
• Hogan M M, Vogel S N. Production of TNF by γ-IFN-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid-A-associated proteins. J Immunol 1988; 121: 4196–4202
   Google Scholar
• Kalter D K, Nakamura M, Turpin J A, Baca L M, Dieffenbach C, Ralph P, Gendelman H E, Meltzer M S. Enhanced HIV replication in MCSF-treated monocytes. J Immunol 1991; 146: 298–306
   PubMedGoogle Scholar
• Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M. Interleukin-1β inhibits long-term potentiation in the CAS region of mouse hippocampal slices. Eur J Pharmacol 1990; 181: 323–326
   Google Scholar
• Kauer J A, Malenka R C, Nicoll R A. NMDA application potentiates synaptic transmission in the hippocampus. Nature 1988; 334: 250–252
   PubMed Web of Science ®Google Scholar
• Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropath, Berlin 1990; 80: 92–94
   PubMed Web of Science ®Google Scholar
• Kim J P, Choi D W. Quinolinate neurotoxicity in cortical cell culture. Neurosci 1987; 25: 423–432
   Google Scholar
• Li A J, Katafuchi T, Oda S, Hori T, Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 1997; 748: 30–38
   Google Scholar
• Lipton S A, Gendelman H E. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995; 332: 934–940
   PubMed Web of Science ®Google Scholar
• Lynch G, Larson J, Kelso S, Barrionuevo G, Schottler F. Intracellular injection of EGTA block induction of hippocampal long-term potentiation. Nature 1983; 305: 719–721
   PubMedGoogle Scholar
• Lynch M A. Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta?. Prog Neurobiol 1998; 56: 571–589
   PubMed Web of Science ®Google Scholar
• Malenka R C, Kauer J A, Zucker R S, Nicoll R A. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 1988; 242: 81–84
   PubMed Web of Science ®Google Scholar
• Masliah E, Achim C L, Ge N, DeTheresa R, Terry R D, Wiley C A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992; 32: 321–329
   PubMed Web of Science ®Google Scholar
• Meucci O, Miller R J. gp120-induced neurotoxicity in hippocampal pyramidal neuron culture: protective action of TGF-β1. J Neurosci 1996; 16: 4080–4088
   Web of Science ®Google Scholar
• Mehler M F, Rozental R, Dougherty M, Spray D C, Kessler J. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 1993; 362: 62–65
   PubMed Web of Science ®Google Scholar
• Michaels J. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodeficiency Review 1988; 1: 71–104
   PubMedGoogle Scholar
• Mrak R E, Sheng J G, Griffin W ST. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 1995; 26: 816–823
   PubMed Web of Science ®Google Scholar
• Muller W EG, Schroder H C, Ushijima H, Dapper J, Bormann J. gp120 of HIV-1 induces apoptosis in rat cortical cell culture: prevention by memantine. Eur J Pharmacol 1992; 226: 209–214
   PubMed Web of Science ®Google Scholar
• Nottet H SLM, Flanagan E M, Flanagan C, Gelbard H A, Gendelman H E, Reinhard J F, Jr. The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes. J NeuroViol 1996; 2: 111–117
   PubMed Web of Science ®Google Scholar
• Nottet H SLM, Jett M, Qu-Hui Z, Flanagan C, Rizzino A, Genis P, Baldwin T, Schwartz J, Gendelman H E. A regulatory role for astrocytes in HIV-1 encephalitis: an over-expression of eicosanoids, platelet activating factor and tumor necrosis factor-α by activated virus-infected monocytes is attenuated by primary human astrocytes. J Immunol 1995; 154: 3567–3581
   PubMed Web of Science ®Google Scholar
• Oshima K H, Comans T W, Highsmith A K, Ades E W. Removal of human immunodeficiency virus by an 0.04-μm membrane filter. J AIDS Human Retrovirol 1995; 8: 64–65
   Google Scholar
• Patterson P H, Nawa H. Neuronal differentiation factors/cytokines and synaptic plasiticity. Cell 72: Neuron 1993; 10: 123–137
   Google Scholar
• Price R W, Sidtis J, Rosenblum M, Scheck A C, Cleary P. The brain and AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239: 586–592
   PubMed Web of Science ®Google Scholar
• Reyes E, Mohar A, Mallory M, Miller A, Masliah E. Hippocampal involvement associated with human immunodeficiency virus encephalitis in Mexico. Arch Pathol Lab Med 1994; 118: 1130–1134
   Google Scholar
• Rothwell N J, Hopkins S J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 1995; 18: 130–136
   PubMed Web of Science ®Google Scholar
• Rothwell N J, Relton J K. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev 1993; 17: 217–227
   PubMed Web of Science ®Google Scholar
• Spencer D C, Price R W. Human immunodeficiency virus and the central nervous system. Ann Rev Microbiol 1992; 46: 655–693
   PubMed Web of Science ®Google Scholar
• Squire L R. Memory and hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992; 99: 195–231
   PubMed Web of Science ®Google Scholar
• Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, Santoni A, Eusebi F. Tumor necrosis factor alters synaptic transmission in the rat hippocampal slices. Neurosci Lett 1992; 146: 176–178
   Web of Science ®Google Scholar
• Tancredi V, Zona C, Velloti F, Eusebi F, Santoni A. Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res 1990; 525: 149–151
   Google Scholar
• Wieraszko A, Li G, Kornecki E, Hohan M V, Ehrlich Y H. Long-term potentiation in the hippocampus induced by platelet-activating factor. Neuron 1993; 10: 553–557
   Google Scholar
• Wiley C A, Masliah E, Morey M, Lemere C, DeTheresa R, Grafe M, Hansen L, Terry R. Neocortical damage during HIV infection. Ann Neurol 1991; 29: 651–657
   PubMed Web of Science ®Google Scholar
• Xiong H, Baskys A, Wojtowicz J M. Brain-derived peptides inhibit synaptic transmission via presynaptic GABAB receptors in CA1 area of rat hippocampal slices. Brain Res 1996; 737: 188–194
   Google Scholar
• Xiong H, Zheng J, Thylin M, Gendelman H E. Unraveling the mechanisms for neurotoxicity in HIV-1-associated dementia: Inhibition of neuronal synaptic transmission by macrophage secretory products. AIDS Res Hum Retrov 1999; 15: 57–63
   Google Scholar
• Zheng J, Gendelman H E. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 1997; 10: 319–325
   PubMed Web of Science ®Google Scholar
• Zheng I, Thylin M R, Persidsky Y, Xiong H, Ghorpade A, Che M, Leisman G B, Cotter R, Gendelman H E. Neuronal destruction in HIV-1-associated dementia: secretory products from HIV-1 infected macrophages affect neuronal function, differentiation, long term potentiation, and viability. J Virol 1999, (revised for publication)
   Google Scholar